APP and myeloid sarcoma: Additionally, 8‐kDa translocator protein (TSPO) positron emission tomography (PET) identified immune cell activation in the brains of living MS patients [9] and AD murine models (amyloid precursor protein (APP)/presenilin 1 (PSEN1)) [10].